购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Endogenous Metabolite
    (1)
  • Others
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (1)
  • 20日内发货
    (1)
  • 35日内发货
    (1)
抑制剂&激动剂
细分筛选
搜索结果
TargetMol产品目录中 "menaquinone-4"的结果
筛选
搜索结果
TargetMol产品目录中 "

menaquinone-4

"的结果
  • 抑制剂&激动剂
    4
    TargetMol | Inhibitors_Agonists
  • 天然产物
    1
    TargetMol | Natural_Products
  • 同位素
    2
    TargetMol | Isotope_Products
  • Menaquinone-4
    四烯甲萘醌, Vitamin K2, Menaquinone K4
    T7106863-61-6
    Menaquinone-4 (Vitamin K2) 是维生素 K 的一种,用作止血剂,有潜力用于骨质疏松的研究。
    • ¥ 145
    In stock
    规格
    数量
  • Menaquinone 4-d7 (Mixture of cis-trans isomers)
    TMIH-03281233937-25-1
    Menaquinone 4-d7 (Mixture of cis-trans isomers) 是 Menaquinone 4 (Mixture of cis-trans isomers) 的氘代化合物。
    • ¥ 15200
    5日内发货
    规格
    数量
  • Boromycin
    T3665934524-20-4
    Boromycin is a boron-containing macrolide antibiotic that has been found in Streptomyces. Boromycin inhibits growth of B. subtilis (MIC = 0.05 μg ml) and induces efflux of potassium ions from B. subtilis without affecting Na+ K+-ATPase activity. It decreases the synthesis of protein, RNA, and DNA in B. subtilis when used at a concentration of 0.05 μg ml. It inhibits the growth of B. halodurans (MIC = 10 ng ml) and inhibits the futalosine pathway of menaquinone synthesis in B. halodurans. Boromycin (3.4 nM) reverses bleomycin-induced cell cycle arrest at the G2 phase in Jurkat cells. It inhibits replication of the HIV-1 strains LAV-1 and RF and the HIV-2 strain LAV-2 in MT-4 cells (IC50s = 0.008, 0.11, and 0.007 μM, respectively). It also inhibits replication of a clinical isolate of HIV-1, strain KK-1, in MT-4 cells and peripheral blood mononuclear cells (PBMCs; IC50s = 0.14 and <0.1 μM, respectively).
    • ¥ 3300
    35日内发货
    规格
    数量
  • MK7-d7
    甲萘醌-d7
    TMID-00611233937-31-9
    MK7-d7 是 MK7 的氘代化合物。MK7 的 CAS 号为 2124-57-4。Menaquinone-7 是一种最早作为抗出血因子被发现的维生素K2家族成员。它是Gla-蛋白羧化反应中最具生物活性的辅因子,补充它也是激活Gla基质蛋白并干预钙化性主动脉瓣狭窄(CAVS)进展的一种药理选择。
    • 待询
    20日内发货
    规格
    数量